The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 546.00
Bid: 542.00
Ask: 550.00
Change: 28.00 (5.41%)
Spread: 8.00 (1.476%)
Open: 518.00
High: 550.00
Low: 518.00
Prev. Close: 518.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MuCell Extrusion LLC Obtains an Exclusive License

14 Aug 2012 07:00

RNS Number : 9308J
Zotefoams PLC
14 August 2012
 



14 August 2012

 

Zotefoams plc

("Zotefoams" or "the Company")

 

 

MuCell Extrusion LLC Obtains an Exclusive License for Styron's

Extruded Styrenic Foam Sheet Patent Portfolio, including Polystyrene, ABS and SAN

 

MuCell Extrusion LLC and Styron (Berwyn, Pennsylvania) have concluded an agreement for MuCell Extrusion LLC to acquire access to Styron's patent portfolio for extrusion of Styrenic resins. This agreement gives MuCell Extrusion and its customers exclusive rights to the Styron patents related to Sheet technology for a wide variety of applications.

 

This agreement creates a significant strategic alliance between two companies with leading experience in the successful development and application of physical blowing agents to produce superior foamed products.

 

The combination of Styron's CO2RE™ technology and MuCell's expertise around technology and hardware is expected to help customers improve their competitive advantage in a shorter timeframe. Sheet for thermoforming, FFS, roll stock, paneling and high volume packaging will all see significant cost reductions by applying this technology.

 

 "CO2RE™ is a patented plastic foaming technology that produces polystyrene sheets with a foamed core layer using physical blowing agents," said John Case, Styrenics Global Marketing Manager, Styron. "The technology provides a good opportunity for the packaging market, where for example dairy and food service industries can improve their sustainability by reducing the density and weight of their product packaging. It also provides benefits in reduced energy and reduced raw material usage, as well as lower packaging waste disposable tax in the EU."

 

"MuCell provides expertise in Process and Equipment development, and Styron offers formulation expertise in resins. We believe this combination will bring significant benefits to our customers," said Mark Lindenfelzer, President of MuCell. "The combination of our own patents and intellectual property, and Styron's patents now gives our customers the opportunity to apply the most advanced foaming technology in their products," he said.

 

About MuCell Technology

MuCell technology is based on the direct injection of atmospheric gas (N2 or CO2) in its supercritical state. MuCell has applied this technology to most plastic materials and processes. Rigid sheet, low-density flexible sheet, Blown film, Cast film, pipe/tubing/profile, and blow molding manufacturing processes are all current applications using MuCell technology. MuCell's innovative and accessible technology brings significant material weight-savings and cost reduction opportunities, without compromising physical product performance.

 

Earlier this year, Dow Chemical and MuCell reached an agreement for MuCell to acquire exclusive rights to Dow's patent portfolio for flat sheet resin technology, and more recently Dow's patents for Foam Film technology.

 

The corporate headquarters of MuCell Extrusion LLC are located at 212 West Cummings Park, Woburn, MA 01810. MuCell Extrusion is a wholly owned subsidiary of Zotefoams plc, UK (ZTF on LSE). For more information, please visit www.mucellextrusion.com.

 

About Styron

Styron is a leading global materials company and manufacturer of plastics, latex and rubber, dedicated to collaborating with customers to deliver innovative and sustainable solutions. Styron's technology is used by customers in industries such as home appliances, automotive, building & construction, carpet, consumer electronics, consumer goods, electrical & lighting, medical, packaging, paper & paperboard, rubber goods and tires. Styron had approximately $6 billion in revenue in 2011, with 20 manufacturing sites around the world, and 2100 employees. More information can be found at www.styron.com.

 

###

 

For Styron editorial information please contact:

Donna St. Germain, Styron

Tel. +1 610 240 3307

stgermain@styron.com

 

 

For information on MuCell Extrusion LLC and Zotefoams plc contact:

 

Zotefoams plc

Clifford Hurst or David Stirling

+44 20 8664 1600

 

FTI Consulting

John Dineen / Victoria Foster Mitchell

+44 20 7831 3113

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKNDDFBKDPFD
Date   Source Headline
14th Aug 20231:51 pmRNSNotification of Transactions of Directors/PDMRs
9th Aug 20233:29 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSInterim Results
19th Jul 20231:29 pmRNSHolding(s) in Company
18th Jul 20237:00 amRNSJoint development agreement for ReZorce®
12th Jul 202311:01 amRNSNotification Of Transactions Of Directors/PDMRs
10th Jul 20237:00 amRNSNotice of results and investor presentation
22nd Jun 20232:20 pmRNSHolding(s) in Company
20th Jun 202310:16 amRNSNotification Of Transactions Of Directors/PDMRs
14th Jun 20237:00 amRNSHolding(s) in Company
13th Jun 20232:55 pmRNSNOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
6th Jun 20231:34 pmRNSNotification Of Transactions Of Directors/PDMRs
6th Jun 20238:00 amRNSNike Exclusivity Agreement Extension
24th May 202311:40 amRNSResult of the 2023 Annual General Meeting
24th May 20237:00 amRNSTrading Update and Chair Succession
12th May 202310:42 amRNSNotification Of Transactions Of Directors/PDMRs
27th Apr 20237:00 amRNSHigh-performance foam in medical facility doors
26th Apr 20235:44 pmRNSNotification Of Transactions Of Directors/PDMRs
26th Apr 20233:39 pmRNSNotification Of Transactions Of Directors/PDMRs
24th Apr 20235:50 pmRNSReplacement Notice Transactions Of Directors/PDMRs
24th Apr 20234:42 pmRNSNotification Of Transactions Of Directors/PDMRs
21st Apr 20237:00 amRNS2022 Annual Report and Notice of the 2023 AGM
19th Apr 20234:41 pmRNSNotification Of Transactions Of Directors/PDMRs
12th Apr 20231:18 pmRNSNotification Of Transactions Of Directors/PDMRs
27th Mar 20234:35 pmRNSPrice Monitoring Extension
22nd Mar 20231:30 pmRNSHolding(s) in Company
21st Mar 20234:10 pmRNSNotification Of Transactions Of Directors/PDMRs
21st Mar 20234:09 pmRNSHolding(s) in Company
21st Mar 20237:00 amRNSPreliminary Results
14th Mar 20234:58 pmRNSHolding(s) in Company
14th Mar 20233:09 pmRNSNotification Of Transactions Of Directors/PDMRs
28th Feb 20237:00 amRNSAward of AA ESG Ratings assessment
15th Feb 20237:00 amRNSNotice of Results
14th Feb 20233:34 pmRNSNotification Of Transactions Of Directors/PDMRs
3rd Feb 20234:35 pmRNSPrice Monitoring Extension
19th Jan 20237:00 amRNSFull Year Trading Update
17th Jan 20237:00 amRNSChair Succession
12th Jan 202311:18 amRNSNotification Of Transactions Of Directors/PDMRs
15th Dec 20227:00 amRNSTrading Update
13th Dec 20224:03 pmRNSNotification Of Transactions Of Directors/PDMRs
6th Dec 20229:42 amRNSNotification Of Transactions Of Directors/PDMRs
5th Dec 202211:34 amRNSNotification Of Transactions Of Directors/PDMRs
14th Nov 202211:27 amRNSNotification Of Transactions Of Directors/PDMRs
14th Nov 20227:00 amRNSAppointment of Joint Broker
9th Nov 20227:00 amRNSAcquisition of the assets and IP of Refour ApS
17th Oct 202211:31 amRNSNotification Of Transactions Of Directors/PDMRs
13th Oct 20227:00 amRNSTrading Update
12th Oct 20224:02 pmRNSNotification Of Transactions Of Directors/PDMRs
11th Oct 20224:41 pmRNSSecond Price Monitoring Extn
11th Oct 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.